TREA

79238519 - KEBIOUS

Follow

Information

  • Trademark
  • 79238519
  • Serial Number
    79238519
  • Registration Number
    5929114
  • Filing Date
    February 12, 2018
    6 years ago
  • Registration Date
    December 10, 2019
    4 years ago
  • Transaction Date
    October 06, 2023
    8 months ago
  • Status Date
    December 10, 2019
    4 years ago
  • Published for Opposition Date
    September 24, 2019
    4 years ago
  • Location Date
    December 10, 2019
    4 years ago
Information
Mark Drawing Code
3000
Mark Identification
KEBIOUS
Case File Statements
  • DM0000: The trademark is consisted of the word "KEBIOUS" in the middle of a helix surrounded by two half-round lines in the upper and lower part respectively, and the outermost circle is consisted by two wheat ears, one on the left side and the other on the right side of the mark.
  • GS0051: Medicines for human purposes, namely, medicines for alleviating constipation; Medicines for human purposes, namely, medicines for the treatment of cardiovascular disease, coronary heart disease, angina pectoris, myocarditis, cardiac arrhythmia, tumors, infectious diseases, autoimmune disease, blood disease, mental illness, ophthalmic disorders, metabolic diseases and disorders in the nature of diabetes, kidney diseases, osteoporosis; anti-viral medicines; anesthetics; antibiotics and bacterial poisons; Medicines for human purposes, namely, biological products, prepared by using biological materials in the nature of microorganisms, cells, and various animal and human tissues and liquids, obtained by biological techniques, namely, genetic engineering, cell engineering, protein engineering, fermentation engineering for the treatment of central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, antipyretic and analgesic purposes, non-steroidal anti-inflammatory purposes, infectious diseases, autoimmune diseases, anti-tumor purposes, hypoglycemic and diuretic purposes, vitamin and hormonal purposes; Medicines for human purposes, namely, parenteral nutrition supplements; capsules for medicines, namely, coated capsule medicines for prevention and treatment of human diseases, namely, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, antipyretic and analgesic purposes, non-steroidal anti-inflammatory purpose, infectious diseases, autoimmune diseases, anti-tumor purposes, hypoglycemic and diuretic purposes, vitamin and hormonal purposes; Capsules for medicines, namely, empty capsules for pharmaceuticals in the nature of hard capsules, soft capsules, enteric capsules, microcapsules, drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals, delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements, coated capsule medicines used for parenteral nutrition supplement; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for reducing cholesterol; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases and arthritis; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia; Pharmaceutical preparation for treating microbial diseases, namely, antibiotics; Pharmaceutical preparations for the treatment of mental illness and ophthalmic disease; Pharmaceutical preparations for contrast agent, infectious disease, blood disease and Kidney disease; pharmaceutical preparations containing chemical drugs and biological products for the prevention and treatment of central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, infectious diseases, autoimmune diseases; pharmaceutical preparations containing chemical drugs and biological products for antipyretic and analgesic purposes, non-steroidal anti-inflammatory purposes, anti-tumor purposes, hypoglycemic and diuretic purposes, vitamin and hormonal purposes and parenteral nutrition purposes; chemico-pharmaceutical preparations for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases and infectious diseases; chemico-pharmaceutical preparations for relief from asthma and coughs; chemico-pharmaceutical preparations for parenteral nutrition purposes, antipyretic and analgesic purposes, non-steroidal anti-inflammatory purpose, anti-tumor purposes, hypoglycemic and diuretic purposes, vitamin and hormonal purposes; vaccines; analgesics; drugs for medical purposes for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, infectious diseases, autoimmune disease; drugs for medical purposes for relief from asthma and coughs; drugs for medical purposes, namely, parenteral nutrition purposes, antipyretic and analgesic purposes, non-steroidal anti-inflammatory purpose, anti-tumor purposes, hypoglycemic and diuretic purposes, vitamin and hormonal purposes; medicinal tea; nerviness, namely, medicinal preparations for support of the nervous system; hormones for medical purposes; yeast for pharmaceutical purposes; narcotics in the nature of prescribed synthetic narcotics, narcotics for medical use; ointments for pharmaceutical purposes, namely, anti-inflammatory ointments, anti-itch ointments, antibiotic ointments, herbal anti-itch ointments for pets, ointments for sunburn; cachets for pharmaceutical purposes for the treatment of anemia, cancer, cardiovascular system diseases, and for relief from asthma and coughs, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, parenteral nutrition, antipyretic and analgesic purposes, non-steroidal anti-inflammatory purpose, infectious disease, autoimmune disease, anti-tumor purposes, hypoglycemic and diuretic purposes, vitamin and hormonal purposes; empty cachets for pharmaceuticals in the nature of hard cachets, soft cachets, enteric cachets, micro cachets, drug delivery agents in the form of cachets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; nutritional supplements containing glycerophosphates, calcium supplements, phosphates; tranquillizers; sterilizing preparations; styptic preparations; sugar for medical purposes; acetates for pharmaceutical purposes, namely, calcium channel blockers, calcium acetate for medical use, pharmaceutical solutions used in dialysis for the prevention and treatment of diseases in humans; biochemical preparations for treatment of tumors and cardiovascular system diseases, namely, antitoxic sera, antitoxins, toxoids, toxins, human and veterinary vaccines; biological tissue cultures for veterinary purposes; bone growth media consisting of biological materials for medical purposes; bone void fillers consisting of biological materials; medical preparations for slimming purposes; chemical preparations for pharmaceutical purposes, all used for treatment of anemia, cardiovascular system diseases, deaden pain and relieving asthma and coughs; biochemical preparations for medical purposes; chemical conductors for electrocardiograph electrodes; paper chemically treated for diagnostic use in the detection of fecal occult blood; glucose for medical purposes; iodides for pharmaceutical purposes, namely, iodine, iodoform, alkaline iodides for pharmaceutical purposes, mineral salts for medical purposes; antibiotics; stem cells for medical purposes; biological tissue cultures for medical purposes; slimming pills for medical purposes; transplants, namely, pharmaceutical preparations for use in tissue and organ transplantation, pharmaceutical preparations for human use for the prevention of solid organ transplant rejection, pharmaceutical preparations for transplantation and transplant-related conditions affecting the kidney, bone graft materials derived from human tissue, processed human donor skin for the replacement of soft tissue, surgical mesh comprised primarily of living tissue, Ex vivo cells, namely, immune cells, red blood cells, T cells, NK cells, islet cells for medical purposes; collagen for medical purposes; plant extracts for pharmaceutical purposes; preparations of microorganisms for medical or veterinary use, namely, antimicrobial preparations for inhibiting microbiological decomposition, antimicrobials for dermatologic use, cultures and preparations of microorganisms for medical purposes, namely, for promoting a healthy gastrointestinal microbiome; injection for medical purposes, namely, auto-injectors prefilled with epinephrine, insulin injectors sold filled with insulin, intravenous fluids used for nutrition, intravenous fluids used for rehydration, intravenous fluids used for the delivery of pharmaceutical preparations; Injections, namely, intravenous injections and subcutaneous injections, containing chemicals, biological products and blood products, namely, pharmaceutical preparations to treat tumors; tablet for medical purposes in the nature of allergy tablets, antibiotic tablets, sleeping tablets, vitamin tablets; Tablets comprising chemicals, biological products and blood products, namely, pharmaceutical preparations to treat tumors; Oral tablets, lozenges, sublingual tablets, oral patches, chewable tablets, dispersible tablets, effervescent tablets, vaginal tablets, immediate and sustained release and controlled release tablets and enteric coated tablets used as drug delivery agents for pharmaceutical preparations; tincture of iodine for medical purposes; aqueous solution for medical purposes, namely, thermal water, vitamin enhanced water, liquid antipruritic, antiseptic liquid bandages, cleaning solutions for contact lenses, irrigating solutions for eye use, pharmaceutical solutions used in dialysis, artificial tears; medical paste, namely, topical anaesthetics, topical analgesics, topical first aid gels, topical gel for treatment of scars; raw material medicine, namely, cellulose ethers for use in the manufacture of pharmaceuticals, dietary fiber for use as an ingredient in the manufacture of dietary supplements, milk sugar for use in the manufacture of pharmaceuticals, siccatives for use in the manufacture of pharmaceuticals, materials for making dental impressions; prepared Chinese medicine, namely, nutritional supplements for general health and well-being made from a combination of Traditional Chinese Medicine ingredients, Chinese herbal cough syrup for medical purposes, botanical supplements for general health and well-being for medical purposes, ginseng capsules for general health and well-being for medical purposes, homeopathic supplement remedies for the treatment of colds and flu, homeopathic supplement remedies for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; biomedicine preparations, namely, proteins, peptides, amino acids and derivatives thereof, polysaccharides, nucleotides and derivatives thereof, lipids, enzymes and coenzymes all used as pharmaceutical preparations used to treat nutrient deficiencies; blood preparations, namely, test strips for measuring blood glucose levels, blood for medical purposes, blood plasma, blood substitutes, cord blood for medical purposes, cord blood for veterinary purposes, human albumin, human placental albumin, intravenous immunoglobulin, intramuscular immunoglobulin, histamine human immunoglobulin, specific immunoglobulin, hepatitis B immunoglobulin, rabies immunoglobulin, tetanus immunoglobulin, human coagulation factor VIII, human prothrombin complex, human fibrinogen, anti-human lymphocyte immunoglobulin all used for medical purposes; processed blood for medicinal or therapeutic purposes; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; radiological contrast substances for medical purposes; bouillons for bacteriological cultures; media for bacteriological cultures; nutritive substances for microorganisms, namely, a nutrient substrate prepared by the combination of different nutrients for the growth and reproduction of microorganisms, plants and animals cells and tissues for medical purposes; dietetic substances adapted for medical use, namely, dietetic substances consisting of vitamins, minerals, amino acids and trace elements; amino acid dietary supplements; vitamin and mineral food supplements; yeast dietary supplements; medicines for veterinary purposes, namely, laxatives for veterinary purposes, pain relief medication for veterinary purposes, suppositories for veterinary purposes; biological preparations for veterinary purposes, namely, veterinary pharmaceutical preparations for respiratory and reproductive diseases in cattle, veterinary pharmaceutical preparations for the treatment of arthritis, muscle soreness and sprains, veterinary pharmaceutical preparations for the treatment of bacterial infections in dogs, veterinary pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections, topical infections; veterinary pharmaceutical preparations for the treatment of infectious diseases, namely, swine dysentery, bacterial enteritis, bluecomb, pneumonia; veterinary pharmaceutical preparations for the treatment of vitamin deficiencies; veterinary preparations for treatment of intestinal bacteria; chemical preparations for veterinary purposes, namely, bacteriological preparations for veterinary purposes, namely, bacteria for the production of biochemicals; biochemical preparations for veterinary purposes for the treatment of tumors
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0351: Import-export agency services; wholesale and retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale and retail store services featuring medicines; wholesale and retail store services featuring pharmaceutical preparations; wholesale and retail store services featuring sanitary preparations; wholesale and retail store services featuring medical supplies; wholesale and retail store services featuring veterinary medicine; wholesale and retail store services featuring veterinary preparations
  • GS0441: Hospital services; health care; medical assistance; pharmaceutical advice; telemedicine services; therapy services, namely, voice and speech therapy services, insomnia therapy services, physiotherapy, psychological counseling services, psychotherapy services, respiratory therapy services, drug rehabilitation counseling services, addiction treatment services; alternative medicine services; convalescent home services
  • GS0101: Needles for medical purposes; syringes for injections for medical purposes; probes for medical purposes; dropper bottles for medical purposes, sold empty; hypodermic syringes; injectors for medical purposes for injecting fluid; vaporizers for medical purposes; medical apparatus and instruments, namely, cups for dispensing medicine; medical apparatus and instruments used for diagnosis, monitoring and treatment purposes used to treat cardiovascular disease; syringes for medical purposes; dialyzers
  • GS0421: Technical research, namely, genetic testing for scientific research purposes, medical research services, pharmaceutical research and development, pharmaceutical research services, providing medical and scientific research information in the field of pharmaceuticals and clinical trials, research and development of vaccines and medicines, zoological research services; technical project studies, namely, engineering services in the field of pharmaceuticals and drug development research of pre-clinical, clinical and manufacturing purposes; scientific laboratory services; research and development of new products for others; chemical analysis; chemistry services, namely, research in the field of chemistry; chemical research; cosmetics research; biological research; conducting clinical trials for others
Case File Event Statements
  • 10/6/2023 - 8 months ago
    34 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 4/2/2023 - a year ago
    33 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 6/5/2020 - 4 years ago
    32 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 3/26/2020 - 4 years ago
    31 - GENERIC MADRID TRANSACTION SENT TO IB Type: XXSS
  • 3/25/2020 - 4 years ago
    30 - GENERIC MADRID TRANSACTION CREATED Type: XXCR
  • 3/10/2020 - 4 years ago
    29 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 12/10/2019 - 4 years ago
    28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/24/2019 - 4 years ago
    27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/24/2019 - 4 years ago
    26 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/20/2019 - 4 years ago
    25 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 9/4/2019 - 4 years ago
    24 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 9/4/2019 - 4 years ago
    23 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 9/4/2019 - 4 years ago
    22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/13/2019 - 4 years ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/13/2019 - 4 years ago
    20 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 8/13/2019 - 4 years ago
    19 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 8/13/2019 - 4 years ago
    18 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 8/13/2019 - 4 years ago
    17 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 2/25/2019 - 5 years ago
    16 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 2/25/2019 - 5 years ago
    15 - FINAL REFUSAL E-MAILED Type: GNFR
  • 2/25/2019 - 5 years ago
    14 - FINAL REFUSAL WRITTEN Type: CNFR
  • 2/2/2019 - 5 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/1/2019 - 5 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/1/2019 - 5 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/1/2018 - 5 years ago
    10 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/15/2018 - 5 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNP
  • 8/30/2018 - 5 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 8/30/2018 - 5 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 8/21/2018 - 5 years ago
    6 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 8/19/2018 - 5 years ago
    5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 8/18/2018 - 5 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/15/2018 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/15/2018 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/9/2018 - 5 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR